Therapeutic Advances in Cardiovascular Disease
(ISSN: 1753-9447, 1753-9455)
This journal no longer participates in Medscape Publishers' Circle Program. No new articles will be republished.
Articles Available on Medscape
Evidence for Cardiovascular, Cerebrovascular, and Renal Protective Effects of Renin-Angiotensin System Blockers
Besides high blood pressure management, what's the rationale and evidence for benefits of RAS blockade?
Preventive Aspects in Peripheral Artery Disease
Learn more about risk factors that contribute to the development of PAD and how they can be modified.
Blood Pressure Lowering and Beyond in Special Populations
Combining agents from different antihypertensive classes significantly increases efficacy and is a recommended treatment strategy, but how does this method pan out for patients with greater severity of illness?
Decorin in Atherosclerosis
What is the role of decorin in attenuating progression of atherosclerosis?
The Effect of Amlodipine Besylate, Losartan Potassium, Olmesartan Medoxomil, and Other Antihypertensives on Central Aortic Blood Pressure and Biomarkers of Vascular Function
What are the long-term, quantifiable cardiovascular benefits from antihypertensive agents, and which biomarkers are most valuable for making this determination?
The Facts Behind Niacin
Niacin is a lipid-altering drug that has been used to lower cholesterol since the 1950s, but what kind of data do we have to support using it?
The Ezetimibe Controversy: Implications for Clinical Practice
The ezetimibe controversy is unraveled by taking a closer look at the most relevant lipids management trials.
Combined Aliskiren-Amlodipine Treatment for Hypertension in African Americans
In the US, race is not considered to be a major factor in drug choice, but in England and other countries, initial therapy with renin-angiotensin system blocking drugs is not recommended in Blacks. Find out why.
Using Impedance Cardiography With Postural Change to Stratify Patients With Hypertension
Can impedance cardiography waveforms help identify the underlying cardiovascular disease associated with hypertension - before it gets a stranglehold on patients?
Epidemic of Cardiometabolic Diseases: A Latin American Point of View
Growing evidence suggests that epigenetic changes such as DNA methylation are prime suspects in the case of cardiovascular disease vs. Latin Americans.
Is Prevention a Fantasy, or the Future of Medicine?
Current evidence supports primordial prevention and pride in cardiovascular health through lifestyle modification.
New Parenteral Anticoagulants in Development
Learn more about the novel compounds in development and how they'll complement established parenteral anticoagulants.
Recent Advances in Oral Anticoagulation for Atrial Fibrillation
Targets for anticoagulant therapy and newer oral anticoagulants for atrial fibrillation are reviewed.
Management of Dyslipidemia in the Elderly Population
What are the differences in changes in lipids that occur in men and women during aging?
Efficacy of Amlodipine and Olmesartan Medoxomil in Patients With Hypertension: The AZOR Trial Evaluating Blood Pressure Reductions and Control (AZTEC) Study
Aggressively high blood pressure calls for antihypertensive treatments that are both effective and easy to adhere to.
Darapladib: An Emerging Therapy for Atherosclerosis
Learn more about this novel treatment aimed at further decreasing complications of atherosclerotic cardiovascular diseases by filling the gaps left by today's standard therapies.
Contemporary Practices in Postcardiac Arrest Syndrome: The Role of Mild Therapeutic Hypothermia
Recent research suggests mild hypothermia treatment (MHT) lowers mortality and improves neurological outcome after successful treatment of cardiac arrest. Why isn't MHT being used more?
Efficacy and Tolerability of Olmesartan/Amlodipine Combination Therapy in Patients With Mild-to-Severe Hypertension: Focus on 24-H Blood Pressure Control
Sustained 24-h BP control is a worthy target goal for hypertension management. Does this combo hit the mark?
The Role of Cellular Micronutrient Analysis, Nutraceuticals, Vitamins, Antioxidants and Minerals in the Prevention and Treatment of Hypertension and Cardiovascular Disease
Diagnosis and treatment of nutrient deficiencies may reduce blood pressure and reduce cardiovascular events.
Aliskiren Versus Ramipril in Hypertension
Three studies are compared to evaluate the antihypertensive effects of these two monotherapies.